Gut-On-A-Chip: Assessing Drug-induced Gut Toxicity In Vitro

Learn how scientists use cells from real human intestine to assess gut toxicity and screen drugs.

Researchers use human stem cell-derived intestinal tissue to assess drug-induced gut toxicity.

The gastrointestinal (GI) tract is one of the most common organs affected by adverse drug reactions. While it is essential to assess GI toxicity early in drug development, traditional toxicity assays using model cell lines do not accurately reflect the human gut. Stem cell-based technologies that recreate the human intestine enable researchers to better evaluate drug-induced GI toxicity during candidate drug screening. In this webinar, experts from Altis Biosystems will discuss the latest advances of GI toxicity assessment empowered by stem cell and organ-on-a-chip technology.

Topics to be covered

  • Challenges of assessing GI risk in drug development
  • Assessing GI toxicity using an in vitro intestinal stem cell model 

Viewers of the webinar will have an opportunity to apply for a free pilot project! Learn more about the pilot project https://www.altisbiosystems.com/pilot-project

Wednesday, July 27th, 2022 | 11:00 AM - 12:30 PM Eastern Time
This webinar will be available to view live and on demand.


Bill Thelin, PhD

Bill Thelin, PhD

Chief Scientific Officer
Altis Biosystems

Bailey Zwarycz, PhD

Bailey Zwarycz, PhD

Associate Director, Commercial Services
Altis Biosystems

Sponsored by